Raymond James & Associates’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.48M | Buy |
|
|||||
|
2024
Q2 | $749K | Sell |
|
|||||
|
2024
Q1 | $908K | Buy |
|
|||||
|
2023
Q4 | $845K | Buy |
|
|||||
|
2023
Q3 | $564K | Buy |
|
|||||
|
2023
Q2 | $642K | Sell |
|
|||||
|
2023
Q1 | $923K | Buy |
|
|||||
|
2022
Q4 | $787K | Buy |
|
|||||
|
2022
Q3 | $375K | Buy |
|
|||||
|
2022
Q2 | $156K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $39K | Hold |
|
|||||
|
2020
Q3 | $35K | Sell |
|
|||||
|
2020
Q2 | $82K | Sell |
|
|||||
|
2020
Q1 | $72K | Sell |
|
|||||
|
2019
Q4 | $102K | Buy |
|
|||||
|
2019
Q3 | $122K | Buy |
|
|||||
|
2019
Q2 | $67K | Buy |
|
|||||
|
2019
Q1 | $66K | Sell |
|
|||||
|
2018
Q4 | $29K | Buy |
|
|||||
|
2018
Q3 | $47K | Buy |
|